US Patent 8202516 Phage derived antimicrobial activities
Patent 8202516 was granted and assigned to GangaGen, Inc. on June, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+266 characters)
Article
Patent abstract
The present invention provides methods and compositions to reduce growth of microbial colonies, including infections, and includes therapeutic compositions, methods for treatment of infections, and methods for identifying additional such compositions.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08202516 Phage derived antimicrobial activities US Patent 8202516 Phage derived antimicrobial activities
Infobox
Patent Number
0820251600
Patent Number
820251600
Edits on 21 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082025160
Date of Patent
June 19, 2012
0Patent Application Number
122996010
Date Filed
May 4, 2007
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082025160
Date of Patent
June 19, 2012
0Patent Application Number
122996010
Date Filed
May 4, 2007
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08202516 Phage derived antimicrobial activities
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08202516
Date of patent
June 19, 2012
Patent application number
12299601
Date Filed
May 4, 2007
Patent primary examiner
Find more entities like US Patent 8202516 Phage derived antimicrobial activities
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
